TIAF1 participates in the transforming growth factor β1-mediated growth regulation

Annals of the New York Academy of Sciences

Volumn 995, Issue , 2003, Pages 11-21

  Khera, Smaira ^a   Chang, Nan Shan ^a  

^a GUTHRIE RESEARCH INSTITUTE   (United States)

Author keywords

p53; Smad; TGF 1; TIAF1; TNF

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; PROTEIN P53; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FIBROBLAST; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA; MURINAE; MUSTELA VISON;

EID: 0038170348     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03206.x     Document Type: Conference Paper

References (22)

1. TEN DIJKE, P., K. MIYAZONO & C.H. HELDIN. 2000. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem. Sci. 25: 64-70.
2. LAWRENCE, D.A. 1996. Transforming growth factor-beta: a general review. Eur. Cytokine Netw. 7: 363-374.
3. REISS, M. & M.H. BARCELLOS-HOFF. 1997. Transforming growth factor-beta in breast cancer: a working hypothesis. Breast Cancer Res. Treat. 45: 81-95.
4. BARRACK, E.R. 1997. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31: 61-70.
5. LETTERIO, J.J. & A.B. ROBERTS. 1998. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16: 137-161.
6. ESPEVIK, T., I.S. FIGARI, G.E. RANGES & M.A. PALLADINO, JR. 1988. Transforming growth factor-beta 1 (TGF-β1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. J. Immunol. 140:2312-2316.
7. RANGES, G.E., I.S. FIGARI, T. ESPEVIK & M.A. PALLADINO, JR. 1987. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 166: 991-998.
8. SNOECK, H.W., S. WEEKX, A. MOULIJN et al. 1996. Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta, but not to interferon gamma. J. Exp. Med. 183: 705-710.
9. CHANG, N-S. 1998. Transforming growth factor-β protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase [review]. Int. J. Mol. Med. 2: 653-659.
10. CHANG, N-S. 1995. Transforming growth factor-beta 1 induction of novel extracellular matrix proteins that trigger resistance to tumor necrosis factor cytotoxicity in murine L929 fibroblasts. J. Biol. Chem. 270: 7765-7772.
11. CHANG, N-S., J. MATTISON, H. CAO et al. 1998. Cloning and characterization of a novel transforming growth factor-betal-induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. Biochem. Biophys. Res. Commun. 253: 743-749.
12. CAREY, G.B. & N-S. CHANG. 1998. Cloning and characterization of a transforming growth factor betal-induced anti-apoptotic adhesion protein TIF2. Biochem. Biophys. Res. Commun. 249: 283-286.
13. CHANG, N-S. 2000. TGF-β-induced matrix proteins inhibit p42/44 MAPK and SAPK/JNK activation and suppress TNF-mediated IκBα degradation and NF-κB nuclear translocation in L929 fibroblasts. Biochem. Biophys. Res. Commun. 267: 194-200.
14. PIACIBELLO, W., A. SEVERINO, A. STACCHINI & M. AGLIETTA. 1991. Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells. Haematologica 76: 460-466.
15. BOMBARA, C. & R.A. IGNOTZ. 1992. TGF-beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells. J. Cell. Physiol. 153: 30-37.
16. DEFACQUE, H., D. PIQUEMAL, A. BASSET et al. 1999. Transforming growth factor-betal is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. J. Cell. Physiol. 178: 109-119.
17. GIVAN, A.L. 1992. Cells from within: DNA and molecular biology. In Flow Cytometry: First Principles, pp. 103-134. Wiley-Liss. New York.
18. RICE, P.L., R.J. GOLDBERG, E.C. RAY et al. 2001. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res. 61: 1541-1547.
19. WENG, L.P., W.M. SMITH, J.L. BROWN & C. ENG. 2001. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum. Mol. Genet. 10: 605-616.
20. HOSHINO, R., S. TANIMURA, K. WATANABE et al. 2000. Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1). J. Biol. Chem. 276: 2686-2692.
21. ROBERTS, A.B., L.C. LAMB, D.L. NEWTON et al. 1980. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl. Acad. Sci. USA 77: 3494-3498.
22. VAN DER LEIJ, J., A. VAN DEN BERG, E.W.J.A. ALBRECHT et al. 2002. High expression of tiaf-1 in chronic kidney and liver allograft rejection and in activated t helper cells. Transplantation. In press.